Persell Stephen D, Lloyd-Jones Donald M, Baker David W
Division of General Internal Medicine, Department of Medicine, and the Department of Preventive Medicine, Feinberg School of Medicine, Northwestern University, Chicago, IL 60611-2927, USA.
J Gen Intern Med. 2006 Feb;21(2):171-6. doi: 10.1111/j.1525-1497.2006.00323.x. Epub 2005 Dec 22.
Modifications to the National Cholesterol Education Program (NCEP) guidelines lowered optional low-density lipoprotein cholesterol (LDL-C) treatment goals.
We evaluated the implications of widely adopting these optional goals in clinical practice.
We performed a cross-sectional study using 1999 to 2002 data from 3,281 U.S. adults aged 20 to 79 years participating the National Health and Nutrition Examination Survey.
The primary outcomes were the proportions of adults whose fasting LDL-C levels exceeded NCEP recommended and optional targets from 2001 and 2004. We used survey weights to estimate the size of the U.S. population exceeding targets. We examined outcomes for 4 coronary disease risk subgroups described by the NCEP.
Low-density lipoprotein cholesterol values exceeded 2001 NCEP goals for 30.0% of adults, and 35.8% had levels above optional 2004 goals. An estimated 24,900,000 individuals (14.2%) exceeded 2001 thresholds for drug therapy, 46,200,000 (26.3%) exceeded optional 2001 thresholds for drug therapy, and 56,500,000 (32.2%) were above the optional 2004 thresholds for drug therapy. For lower, moderate, moderately high, and high-risk groups, 13.4%, 44.2%, 58.8%, and 71.8%, respectively, exceeded 2001 NCEP goals; 13.4%, 15.7%, 87.4%, and 96.0% of these groups exceeded optional 2004 thresholds for drug therapy.
In 1999 to 2002, LDL-C levels commonly exceeded 2001 NCEP goals, especially for moderately high and high-risk individuals, and cholesterol-lowering medications were underused. Optional goals promulgated by the NCEP in 2001 and 2004 moderately increased the number of adults with LDL-C above their goal, and greatly increased the number of low, moderately high, and high-risk adults who exceeded LDL-C thresholds, for cholesterol-lowering medication.
美国国家胆固醇教育计划(NCEP)指南的修订降低了低密度脂蛋白胆固醇(LDL-C)的可选治疗目标。
我们评估了在临床实践中广泛采用这些可选目标的影响。
我们使用1999年至2002年参加美国国家健康和营养检查调查的3281名20至79岁美国成年人的数据进行了一项横断面研究。
主要结果是空腹LDL-C水平超过2001年和2004年NCEP推荐目标及可选目标的成年人比例。我们使用调查权重来估计美国超过目标的人口规模。我们检查了NCEP描述的4个冠心病风险亚组的结果。
30.0%的成年人LDL-C值超过2001年NCEP目标,35.8%的人LDL-C水平高于2004年可选目标。估计有2490万人(14.2%)超过了2001年药物治疗阈值,4620万人(26.3%)超过了2001年药物治疗可选阈值,5650万人(32.2%)高于2004年药物治疗可选阈值。对于低风险、中度风险、中度高风险和高风险组,分别有13.4%、44.2%、58.8%和71.8%的人超过了2001年NCEP目标;这些组中分别有即13.4%、15.7%、87.4%和96.0%的人超过了2004年药物治疗可选阈值。
在1999年至2002年期间,LDL-C水平普遍超过2001年NCEP目标,尤其是中度高风险和高风险个体,且降胆固醇药物使用不足。NCEP在2001年和2004年颁布的可选目标适度增加了LDL-C高于目标的成年人数量,并大幅增加了LDL-C超过降胆固醇药物阈值的低风险、中度高风险和高风险成年人数量。